Axsome Therapeutics Inc (AXSM)
74.16
-0.73
(-0.97%)
USD |
NASDAQ |
May 02, 16:00
74.17
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Revenue (Quarterly): 71.53M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 71.53M |
September 30, 2023 | 57.79M |
June 30, 2023 | 46.70M |
March 31, 2023 | 94.58M |
Date | Value |
---|---|
December 31, 2022 | 24.37M |
September 30, 2022 | 16.85M |
June 30, 2022 | 8.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.82M
Minimum
Jun 2022
94.58M
Maximum
Mar 2023
45.81M
Average
46.70M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
Amgen Inc | 8.196B |
Vertex Pharmaceuticals Inc | 2.518B |
Krystal Biotech Inc | 42.14M |
Alnylam Pharmaceuticals Inc | 439.72M |
Catalyst Pharmaceuticals Inc | 110.57M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -98.65M |
Total Expenses (Quarterly) | 126.60M |
EPS Diluted (Quarterly) | -2.08 |
Enterprise Value | 3.305B |
Gross Profit Margin (Quarterly) | 89.69% |
Profit Margin (Quarterly) | -137.9% |
Earnings Yield | -7.01% |
Normalized Earnings Yield | -5.609 |